Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Irit Avivi(Tel Aviv Sourasky Medical Center), Hervé Tilly(Centre Virchow-Villermé), Leo F. Verdonck(Isala), N. Russell(Nottingham City Hospital), Silvia Montoto(Queen Mary University of London), Jürgen Finke(University Medical Center Freiburg), Renato Fanin(University of Udine), J Maertens(Universitair Ziekenhuis Leuven), Yves Béguin(University of Liège), Haifa Kathrin Al‐Ali(University Hospital in Halle), Jan J. Cornelissen(Erasmus MC), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Kirsty Thomson(University College Hospital), Gérard Socié(Délégation Paris 7), A Schattenberg(Radboud University Nijmegen), Jean‐Paul Vernant(Hôpital Saint-Jacques), Guido Kobbe(Düsseldorf University Hospital), Ghulam J. Mufti(King's College London)
Cited by 41
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
|Journal of Clinical Oncology|2009|963
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|920